These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25532017)

  • 1. Epigenetics: novel therapeutics targeting epigenetics.
    Conway SJ; Woster PM; Shen JK; Georg G; Wang S
    J Med Chem; 2015 Jan; 58(2):523-4. PubMed ID: 25532017
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the potential of epigenetics in drug development?
    Lundstrom K
    Future Med Chem; 2015; 7(3):239-42. PubMed ID: 25826357
    [No Abstract]   [Full Text] [Related]  

  • 3. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
    Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
    Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics and complex disease: from etiology to new therapeutics.
    Ptak C; Petronis A
    Annu Rev Pharmacol Toxicol; 2008; 48():257-76. PubMed ID: 17883328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetic code in depression: implications for treatment.
    Schroeder M; Hillemacher T; Bleich S; Frieling H
    Clin Pharmacol Ther; 2012 Feb; 91(2):310-4. PubMed ID: 22205200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and depression: current challenges and new therapeutic options.
    Schroeder M; Krebs MO; Bleich S; Frieling H
    Curr Opin Psychiatry; 2010 Nov; 23(6):588-92. PubMed ID: 20644477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cancer drugs based on epigenetics, miRNAs and their interactions.
    Roukos DH
    Epigenomics; 2011 Dec; 3(6):675-8. PubMed ID: 22126285
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetic targeting in pancreatic cancer.
    van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
    Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic therapies reach main street.
    Bates SE
    Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
    [No Abstract]   [Full Text] [Related]  

  • 11. Fooling mother nature: epigenetics and novel treatments for psychiatric disorders.
    Stahl SM
    CNS Spectr; 2010 Jun; 15(6):358-65. PubMed ID: 20625368
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
    Eglen RM; Reisine T
    J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

  • 14. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells.
    Bar-Sela G; Jacobs KM; Gius D
    Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
    Cowan LA; Talwar S; Yang AS
    Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting oxidative stress in cancer.
    Lawless MW; O'Byrne KJ; Gray SG
    Expert Opin Ther Targets; 2010 Nov; 14(11):1225-45. PubMed ID: 20942747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics, DNA methylation, and chromatin modifying drugs.
    Szyf M
    Annu Rev Pharmacol Toxicol; 2009; 49():243-63. PubMed ID: 18851683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting chromatin in fungal pathogens as a novel therapeutic strategy: histone modification gets infectious.
    Hnisz D; Tscherner M; Kuchler K
    Epigenomics; 2011 Apr; 3(2):129-32. PubMed ID: 22122275
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
    Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
    Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are epigenetic drugs for diabetes and obesity at our door step?
    Arguelles AO; Meruvu S; Bowman JD; Choudhury M
    Drug Discov Today; 2016 Mar; 21(3):499-509. PubMed ID: 26697737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.